ERMITE CARIS-BARLATIER: Open Payments
NPI 1083185169 · WILDWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,052 in 27 payments from 17 companies in 2025. Trend: 2023 $158 · 2024 $1,010 · 2025 $2,052
Food & beverage: $2,052
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $388 |
| Amgen Inc. | 2 | $216 |
| AstraZeneca Pharmaceuticals LP | 2 | $157 |
| Boston Scientific Corporation | 1 | $150 |
| ABBVIE INC. | 2 | $148 |
| Dexcom, Inc. | 1 | $132 |
| Actelion Pharmaceuticals US, Inc. | 1 | $127 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Otsuka America Pharmaceutical, Inc. | 1 | $105 |
| Smith+Nephew, Inc. | 1 | $102 |
Products named: EVENITY, REXULTI, WATCHMAN FLX, Wegovy, DEXCOM G7 GSS (161), UPTRAVI, Ozempic, QULIPTA.
Industry payments across FL — which companies pay providers there.
